Filter
3814
Filtered Results: 3814
Text search:
electronic
health
Featured
Recommendations
359
New Publications
918
Language
Document type
No document type
1814
Studies & Reports
728
Guidelines
622
Manuals
307
Strategic & Response Plan
154
Fact sheets
69
Training Material
67
Situation Updates
26
Resource Platforms
11
Brochures
8
Infographics
5
Online Courses
3
Countries / Regions
Global
195
India
170
Kenya
98
South Africa
78
Nigeria
69
Uganda
65
Ethiopia
63
Latin America and the Carribbean
62
Sierra Leone
59
Western and Central Europe
59
Nepal
55
Bangladesh
50
Myanmar / Burma
49
Rwanda
48
Africa
48
Ukraine
46
Ghana
46
Malawi
45
Liberia
45
Namibia
41
Tanzania
38
Zambia
37
Syria
28
Eastern Europe
26
Indonesia
26
Colombia
24
Venezuela
24
Zimbabwe
21
South–East Asia Region
20
Philippines
19
Mozambique
18
Brazil
18
Peru
17
Asia
17
Congo, Democratic Republic of
16
East and Southern Africa
16
Botswana
16
Lesotho
15
Paraguay
15
Russia
15
Cambodia
14
Argentina
14
Guinea
13
Haiti
13
Pakistan
13
West and Central Africa
11
Germany
10
Eswatini/ Swaziland
10
Chile
9
Jordan
9
Ecuador
9
Tajikistan
8
Benin
8
Cameroon
8
Middle East and North Africa
8
Spain
8
Burkina Faso
7
Afghanistan
7
Lebanon
7
Yemen
7
Angola
7
Thailand
6
El Salvador
6
Albania
6
Senegal
6
USA
6
Eastern Europe and Central Asia
6
South Sudan
6
Iraq
6
Guinea-Bissau
5
Bolivia
5
Papua New Guinea
5
Moldova
5
Sri Lanka
5
North Macedonia
4
Timor Leste/ East Timor
4
Kazakhstan
4
Iran
4
Laos
4
Kyrgyzstan
4
Georgia
4
Honduras
4
Mexico
3
China
3
Uzbekistan
3
Armenia
3
Dominican Republic
3
Western Pacific Region
3
Uruguay
3
Turkmenistan
3
United Kingdom
3
Southern Africa
3
Côte d’Ivoire / Ivory Coast
3
Nicaragua
3
Sudan
3
Central African Republic
3
Mali
3
Somalia
3
Guatemala
3
Serbia
2
Croatia
2
Saudi Arabia
2
North America
2
Vietnam
2
Egypt
2
Chad
2
Libya
2
Bhutan
2
Madagascar
2
North Korea
1
Turkey
1
Australia
1
Gambia
1
Canada
1
Fiji
1
Estonia
1
Burundi
1
Malaysia
1
Morocco
1
Qatar
1
Bulgaria
1
Lithuania
1
Gabon
1
Jamaica
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Azerbaijan
1
Latvia
1
Belize
1
Costa Rica
1
Panama
1
Romania
1
Greece
1
Palestine
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
1369
Clinical Guidelines
358
Public Health
230
Key Resources
220
Women & Child Health
202
Pharmacy & Technologies
77
Capacity Building
71
Toolboxes
COVID-19
305
HIV
252
TB
247
Mental Health
245
AMR
149
Caregiver
139
Planetary Health
134
NTDs
124
Disability
122
Rapid Response
113
NCDs
105
Pharmacy
82
Conflict
81
Ebola & Marburg
75
Global Health Education
63
Refugee
59
Malaria
56
Natural Hazards
51
Specific Hazards
35
Health Financing Toolbox
29
Zika
28
Polio
14
Cholera
13
Social Ethics
11
2.0 Rapid Response
3
Typhoon
3
The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four health outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting o...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
World Health Organization. (2022). Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 4: developing an implementation plan.
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Globally, 311,000 women die of cervical cancer every year, 85 percent of them
in resource limited regions of the world. To address this grave threat to women,
the WHO made a call to action in 2018, resulting in accelerated plans to improve
cervical cancer control under the elimination threshold w...
A sanitary inspection is a simple, on-site evaluation (traditionally using a checklist) to help identify and support the management of priority risk factors that may lead to contamination of a drinking-water supply. Sanitary inspections are a well-established and widely-applied practice. They can su...
COVID-19 has heavily emphasized how contact tracing is crucial for managing outbreaks, and as part of the strategy for adjusting, and eventually lifting, lockdowns and other stringent public health and social measures. As the pandemic develops further, it will be a core measure to manage further wav...
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti...
Guide for clinical case management and infection prevention and control during ameasles outbreak. This guide has been developed to reduce the high morbidity and mortality seen in some of the current outbreaks of measles. This short guide outlines practical clinical care interventions and is derived ...
Technology landscape
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
The toolkit provides practical guidance and tools that can support efforts, including planning and implementation activities, to create dementia-inclusive societies.
The toolkit is divided into two parts. Part I contains background information and a conceptual framework for creating dementia-incl...
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this inclu...
Key stakeholders must be involved in the planning, implementation, monitoring and evaluation of NCD plans and programmes. Within a ministry of health there will be different types of stakeholders, such as programme managers and senior managers in departments of prevention, health promotion, and hosp...
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical ...
